Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults

Thomas G. Martin, James L. Gajewski

    Research output: Contribution to journalArticle

    29 Scopus citations

    Abstract

    Acute lymphocytic leukemia remains a difficult disease to treat in adults. Allogeneic bone marrow transplantation can cure some patients with ALL, but GVHD transplant-related mortality and disease relapse remain problematic. Immunotherapeutic approaches aimed at eliminating minimal residual disease and enhancing the GVL effect may decrease relapse rates and improve overall survival. Because of the rarity of this disease in adults, every new patient should be entered in well-designed, peer-reviewed, investigational trial.

    Original languageEnglish (US)
    Pages (from-to)97-120
    Number of pages24
    JournalHematology/Oncology Clinics of North America
    Volume15
    Issue number1
    DOIs
    StatePublished - Jan 1 2001

    ASJC Scopus subject areas

    • Hematology
    • Oncology

    Fingerprint Dive into the research topics of 'Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults'. Together they form a unique fingerprint.

  • Cite this